Co-Authors
This is a "connection" page, showing publications co-authored by Philippe Colson and Jean-Christophe Lagier.
Connection Strength
3.968
-
A Possible Role of Remdesivir and Plasma Therapy in the Selective Sweep and Emergence of New SARS-CoV-2 Variants. J Clin Med. 2021 Jul 24; 10(15).
Score: 0.240
-
SARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment. Viruses. 2021 05 12; 13(5).
Score: 0.236
-
Spreading of a new SARS-CoV-2 N501Y spike variant in a new lineage. Clin Microbiol Infect. 2021 Sep; 27(9):1352.e1-1352.e5.
Score: 0.236
-
Introduction into the Marseille geographical area of a mild SARS-CoV-2 variant originating from sub-Saharan Africa: An investigational study. Travel Med Infect Dis. 2021 Mar-Apr; 40:101980.
Score: 0.232
-
Interpretation of SARS-CoV-2 PCR results for the diagnosis of COVID-19. Int J Antimicrob Agents. 2021 Jan; 57(1):106238.
Score: 0.230
-
Coinfections with SARS-CoV-2 and other respiratory viruses in Southeastern France: A matter of sampling time. J Med Virol. 2021 04; 93(4):1878-1881.
Score: 0.230
-
Evidence of SARS-CoV-2 re-infection with a different genotype. J Infect. 2021 04; 82(4):84-123.
Score: 0.228
-
Temporal and age distributions of SARS-CoV-2 and other coronaviruses, southeastern France. Int J Infect Dis. 2020 Dec; 101:121-125.
Score: 0.226
-
Children account for a small proportion of diagnoses of SARS-CoV-2 infection and do not exhibit greater viral loads than adults. Eur J Clin Microbiol Infect Dis. 2020 Oct; 39(10):1983-1987.
Score: 0.225
-
Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis. Travel Med Infect Dis. 2020 Jul - Aug; 36:101791.
Score: 0.222
-
Ultrarapid diagnosis, microscope imaging, genome sequencing, and culture isolation of SARS-CoV-2. Eur J Clin Microbiol Infect Dis. 2020 Aug; 39(8):1601-1603.
Score: 0.219
-
Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine? Travel Med Infect Dis. 2020 Mar - Apr; 34:101624.
Score: 0.218
-
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents. 2020 04; 55(4):105932.
Score: 0.218
-
Letter to the editor: Plenty of coronaviruses but no SARS-CoV-2. Euro Surveill. 2020 02; 25(8).
Score: 0.216
-
SARS-CoV-2 Infectivity and Severity of COVID-19 According to SARS-CoV-2 Variants: Current Evidence. J Clin Med. 2021 Jun 15; 10(12).
Score: 0.059
-
Clinical outcomes in COVID-19 patients infected with different SARS-CoV-2 variants in Marseille, France. Clin Microbiol Infect. 2021 Oct; 27(10):1516.e1-1516.e6.
Score: 0.059
-
Emergence and outcomes of the SARS-CoV-2 'Marseille-4' variant. Int J Infect Dis. 2021 May; 106:228-236.
Score: 0.059
-
COVID-19 re-infection. Eur J Clin Invest. 2021 May; 51(5):e13537.
Score: 0.058
-
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited. Int J Antimicrob Agents. 2021 Jan; 57(1):106243.
Score: 0.058
-
Natural history of COVID-19 and therapeutic options. Expert Rev Clin Immunol. 2020 12; 16(12):1159-1184.
Score: 0.058
-
Different pattern of the second outbreak of COVID-19 in Marseille, France. Int J Infect Dis. 2021 Jan; 102:17-19.
Score: 0.057
-
Does spitting in public play a role in transmitting SARS-CoV-2? Travel Med Infect Dis. 2020 Jul - Aug; 36:101759.
Score: 0.055
-
Comparison of mortality associated with respiratory viral infections between December 2019 and March 2020 with that of the previous year in Southeastern France. Int J Infect Dis. 2020 Jul; 96:154-156.
Score: 0.055
-
Child with liver transplant recovers from COVID-19 infection. A case report. Arch Pediatr. 2020 Jul; 27(5):275-276.
Score: 0.055
-
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France. Travel Med Infect Dis. 2020 May - Jun; 35:101738.
Score: 0.055
-
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study. Travel Med Infect Dis. 2020 Mar - Apr; 34:101663.
Score: 0.055
-
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020 Jul; 56(1):105949.
Score: 0.055
-
Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: A respiratory virus snapshot. Travel Med Infect Dis. 2020 Jul - Aug; 36:101632.
Score: 0.055